{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/993 (Done on website).pdf"}, "page_content": "B) administering to the subject near-infrared radiation (NIR).\n\nthe\n\nof\n\n6) A method for manufacturing a platinum(IV) complex Formula II(b) of claim 4, comprising the steps of:\n\n10) The method of treating cancer, a tumor, or an infection in a subject according to claim 10, wherein the NIR has a wavelength from about 700 nm to about 1400 nm.\n\nof\n\nA) providing a platinum([V) complex of Formula II(a);\n\nB) providing an NHS ester of 5,6-dimethylxanthenone- 4-acetic acid; and\n\nC) reacting the platinum(IV) complex of Formula II(a) with the NHS ester of 5,6-dimethylxanthenone-4-acetic acid to form the platinum(IV) complex of Formula\n\n7) A method for manufacturing a platinum(IV) complex Formula II(c) of claim 4, comprising the steps of:\n\ndihydroxido platinum(IV);\n\nin is\n\n11) The method of treating cancer, a tumor, or an infection a subject according to claim 9, wherein the effective dose from about 0.1 mg/kg to about 90 mg/kg, based on weight of the patient.\n\n12) The method of treating cancer, a tumor, or an infection a subject according to claim 9, wherein the cancer, tumor, infection exhibits cisplatin resistance, platinum resis- tance, PDT resistance, and a combination thereof.\n\nin\n\nor\n\n13) The method of treating cancer, a tumor, or an infection a subject according to claim 9, wherein the infection a bacterial infection.\n\nin comprises\n\nthe\n\nproviding a NHS ester of 3-((4-(3-(7-(diethylamino)- 2-oxochroman-3-yl)-3-oxoprop-1-en-1-yl)phenyl) (methylamino)propanoic acid;\n\nB)\n\nC) reacting diammine (cyclobutane-1,1 dicarboxylato) dihydroxido platinum(IV) with the NHS ester of 3-((4- (3-(7-(diethylamino)-2-oxochroman-3-yl)-3-oxoprop- -en-1-yl)phenyl)(methyljamino)propanoic acid to form the platinum(IV) complex of Formula II(c).\n\n14) The method of treating cancer, a tumor, or an infection a subject according to claim 13, wherein the bacteria comprises Gram-negative bacteria, Gram-positive bacteria, and a combination thereof.\n\nin", "type": "Document"}}